Subtype
Spinal Cord Neoplasm
CI-CAN-00001540Explore in graph →
Non-malignant7 active trials1 evidence items
Loading cancer entity…
Subtype
CI-CAN-00001540Explore in graph →
Clinical trials
54 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01088763 | Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia | terminated | Phase 1 | 129 | National Cancer Institute (NCI)NIH | 2 | Nov 5, 2014 | clinicaltrials |
| NCT01407341 | Beta-Tricalcium Phosphate Bone Graft in Treating Patients Undergoing Surgery For Metastatic Spine Cancer | terminated | Phase 1 | 1 | University of Southern CaliforniaOTHER | 1 | Feb 6, 2014 |
Data updated 22 days agoSource updated Nov 5, 2014source: clinicaltrials